Biocon Share Price Target 2025:- Biocon’s share price target for 2025 will depend on its growth in biosimilars, new drug approvals, and expansion in global markets. The company’s strong pipeline, strategic partnerships, and focus on research could support steady growth. However, challenges like regulatory delays, pricing pressure, and competition in the pharmaceutical sector may impact performance. Biocon Share Price on NSE as of 25 February 2025 is 322.20 INR.
Biocon Ltd: Current Market Overview
- Open: 324.05
- High: 329.00
- Low: 321.15
- Mkt cap: 38.59KCr
- P/E ratio: 47.92
- Div yield: 0.16%
- 52-wk high: 404.70
- 52-wk low: 244.55
Biocon Share Price Chart
Biocon Share Price Target 2025 (Prediction)
Biocon Share Price Target Years | Biocon Share Price Target Months | Share Price Target |
Biocon Share Price Target 2025 | January | – |
Biocon Share Price Target 2025 | February | ₹330 |
Biocon Share Price Target 2025 | March | ₹337 |
Biocon Share Price Target 2025 | April | ₹343 |
Biocon Share Price Target 2025 | May | ₹350 |
Biocon Share Price Target 2025 | June | ₹357 |
Biocon Share Price Target 2025 | July | ₹363 |
Biocon Share Price Target 2025 | August | ₹370 |
Biocon Share Price Target 2025 | September | ₹377 |
Biocon Share Price Target 2025 | October | ₹387 |
Biocon Share Price Target 2025 | November | ₹397 |
Biocon Share Price Target 2025 | December | ₹405 |
Biocon Shareholding Pattern
- Promoters: 60.64%
- FII: 5.66%
- DII: 15.37%
- Public: 18.34%
Key Factors Affecting Biocon Share Price Growth
-
Expansion in Biologics & Biosimilars – Biocon’s strong pipeline of biosimilars and biologics, along with global regulatory approvals, can boost revenue growth.
-
Strategic Partnerships – Collaborations with global pharma companies for drug development and commercialization will strengthen market presence.
-
New Product Launches – The success of new drugs in key markets like the US and Europe can significantly drive growth.
-
Regulatory Approvals – Faster approvals for biosimilars and new formulations will enhance Biocon’s market share and profitability.
-
R&D and Innovation – Increased investment in research and development can lead to breakthrough therapies, improving long-term business prospects.
Risks and Challenges for Biocon Share Price
-
Regulatory Hurdles – Delays or rejections in drug approvals from regulatory bodies like the US FDA and EMA can impact growth.
-
Competitive Pressure – Strong competition from global pharmaceutical companies in the biosimilars and generics market may affect Biocon’s market share.
-
Pricing and Margin Pressure – Price controls, discounts, and cost competition in key markets can impact profitability.
-
Supply Chain Disruptions – Issues in raw material procurement, manufacturing, or global logistics could lead to production delays.
-
Currency Fluctuations – As Biocon has a strong global presence, exchange rate volatility can affect revenues and profitability.
Read Also:- Share Market Update – ABB Share Price Target 2025